Warner-Lambert: The Virtues and Costs of Focus
Executive SummaryReckoned among the drug industry's walking dead, Warner-Lambert focused its limited resources on the marketing and development of a handful of compounds, succeeded brilliantly--and saved the company. But what did this focus cost?
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.